Background and purpose: There are other options open to patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are non-responders to conventional treatment, including immunosuppressive and immunomodulatory agents (IA). The aim of this study was to assess whether the use of IA is able to increase the number of responders.
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy : a nationwide retrospective analysis / D. Cocito, S. Grimaldi, L. Paolasso, Y. Falcone, G. Antonini, L. Benedetti, C. Briani, R. Fazio, S. Jann, S. Matà, M. Sabatelli, E. Nobile-Orazio. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - 18:12(2011), pp. 1417-1421.
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy : a nationwide retrospective analysis
E. Nobile-OrazioUltimo
2011
Abstract
Background and purpose: There are other options open to patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are non-responders to conventional treatment, including immunosuppressive and immunomodulatory agents (IA). The aim of this study was to assess whether the use of IA is able to increase the number of responders.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.